FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134700979> ?p ?o ?g. }

• W3134700979 endingPage "343" @default.
• W3134700979 startingPage "331" @default.
• W3134700979 abstract "Abstract To identify the prognostic factors that are useful to improve central nervous system (CNS) control in children with acute lymphoblastic leukemia (ALL), we analyzed the outcome of 7640 consecutive patients treated on Chinese Children’s Cancer Group ALL-2015 protocol between 2015 and 2019. This protocol featured prephase dexamethasone treatment before conventional remission induction and subsequent risk-directed therapy, including 16 to 22 triple intrathecal treatments, without prophylactic cranial irradiation. The 5-year event-free survival was 80.3% (95% confidence interval [CI], 78.9-81.7), and overall survival 91.1% (95% CI, 90.1-92.1). The cumulative risk of isolated CNS relapse was 1.9% (95% CI, 1.5-2.3), and any CNS relapse 2.7% (95% CI, 2.2-3.2). The isolated CNS relapse rate was significantly lower in patients with B-cell ALL (B-ALL) than in those with T-cell ALL (T-ALL) (1.6%; 95% CI, 1.2-2.0 vs 4.6%; 95% CI, 2.9-6.3; P &lt; .001). Independent risk factors for isolated CNS relapse included male sex (hazard ratio [HR], 1.8; 95% CI, 1.1-3.0; P = .03), the presence of BCR-ABL1 fusion (HR, 3.8; 95% CI, 2.0-7.3; P &lt; .001) in B-ALL, and presenting leukocyte count ≥50×109/L (HR, 4.3; 95% CI, 1.5-12.2; P = .007) in T-ALL. Significantly lower isolated CNS relapse was associated with the use of total intravenous anesthesia during intrathecal therapy (HR, 0.2; 95% CI, 0.04-0.7; P = .02) and flow cytometry examination of diagnostic cerebrospinal fluid (CSF) (HR, 0.2; 95% CI, 0.06-0.6; P = .006) among patients with B-ALL. Prephase dexamethasone treatment, delayed intrathecal therapy, use of total intravenous anesthesia during intrathecal therapy, and flow cytometry examination of diagnostic CSF may improve CNS control in childhood ALL. This trial was registered with the Chinese Clinical Trial Registry (ChiCTR-IPR-14005706)." @default.
• W3134700979 created "2021-03-15" @default.
• W3134700979 creator A5000726024 @default.
• W3134700979 creator A5003759585 @default.
• W3134700979 creator A5014575743 @default.
• W3134700979 creator A5014676719 @default.
• W3134700979 creator A5018363328 @default.
• W3134700979 creator A5020088480 @default.
• W3134700979 creator A5020660748 @default.
• W3134700979 creator A5020924929 @default.
• W3134700979 creator A5024662505 @default.
• W3134700979 creator A5030981796 @default.
• W3134700979 creator A5033718291 @default.
• W3134700979 creator A5036392227 @default.
• W3134700979 creator A5036713963 @default.
• W3134700979 creator A5037796472 @default.
• W3134700979 creator A5044084703 @default.
• W3134700979 creator A5050284408 @default.
• W3134700979 creator A5050733356 @default.
• W3134700979 creator A5050892306 @default.
• W3134700979 creator A5055160753 @default.
• W3134700979 creator A5055585688 @default.
• W3134700979 creator A5057538695 @default.
• W3134700979 creator A5059665113 @default.
• W3134700979 creator A5062161921 @default.
• W3134700979 creator A5063641621 @default.
• W3134700979 creator A5066716873 @default.
• W3134700979 creator A5068281670 @default.
• W3134700979 creator A5071092152 @default.
• W3134700979 creator A5080177510 @default.
• W3134700979 creator A5082600835 @default.
• W3134700979 creator A5089102300 @default.
• W3134700979 date "2021-03-08" @default.
• W3134700979 modified "2023-10-02" @default.
• W3134700979 title "Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation" @default.
• W3134700979 cites W1485852181 @default.
• W3134700979 cites W1837586712 @default.
• W3134700979 cites W1939017986 @default.
• W3134700979 cites W2007254620 @default.
• W3134700979 cites W2014561096 @default.
• W3134700979 cites W2059999488 @default.
• W3134700979 cites W2073140442 @default.
• W3134700979 cites W2106616668 @default.
• W3134700979 cites W2127016956 @default.
• W3134700979 cites W2132079316 @default.
• W3134700979 cites W2134118606 @default.
• W3134700979 cites W2153818728 @default.
• W3134700979 cites W2163926478 @default.
• W3134700979 cites W2167086064 @default.
• W3134700979 cites W2238009057 @default.
• W3134700979 cites W2311406774 @default.
• W3134700979 cites W2408524419 @default.
• W3134700979 cites W2413038045 @default.
• W3134700979 cites W2619874848 @default.
• W3134700979 cites W2745522463 @default.
• W3134700979 cites W2774558437 @default.
• W3134700979 cites W2784353927 @default.
• W3134700979 cites W2811286257 @default.
• W3134700979 cites W2918708984 @default.
• W3134700979 cites W2951953464 @default.
• W3134700979 cites W2973595186 @default.
• W3134700979 cites W2977606681 @default.
• W3134700979 cites W2978917647 @default.
• W3134700979 cites W2982248350 @default.
• W3134700979 cites W3000081737 @default.
• W3134700979 cites W3063038225 @default.
• W3134700979 doi "https://doi.org/10.1182/blood.2020010438" @default.
• W3134700979 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8323972" @default.
• W3134700979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33684941" @default.
• W3134700979 hasPublicationYear "2021" @default.
• W3134700979 type Work @default.
• W3134700979 sameAs 3134700979 @default.
• W3134700979 citedByCount "40" @default.
• W3134700979 countsByYear W31347009792021 @default.
• W3134700979 countsByYear W31347009792022 @default.
• W3134700979 countsByYear W31347009792023 @default.
• W3134700979 crossrefType "journal-article" @default.
• W3134700979 hasAuthorship W3134700979A5000726024 @default.
• W3134700979 hasAuthorship W3134700979A5003759585 @default.
• W3134700979 hasAuthorship W3134700979A5014575743 @default.
• W3134700979 hasAuthorship W3134700979A5014676719 @default.
• W3134700979 hasAuthorship W3134700979A5018363328 @default.
• W3134700979 hasAuthorship W3134700979A5020088480 @default.
• W3134700979 hasAuthorship W3134700979A5020660748 @default.
• W3134700979 hasAuthorship W3134700979A5020924929 @default.
• W3134700979 hasAuthorship W3134700979A5024662505 @default.
• W3134700979 hasAuthorship W3134700979A5030981796 @default.
• W3134700979 hasAuthorship W3134700979A5033718291 @default.
• W3134700979 hasAuthorship W3134700979A5036392227 @default.
• W3134700979 hasAuthorship W3134700979A5036713963 @default.
• W3134700979 hasAuthorship W3134700979A5037796472 @default.
• W3134700979 hasAuthorship W3134700979A5044084703 @default.
• W3134700979 hasAuthorship W3134700979A5050284408 @default.
• W3134700979 hasAuthorship W3134700979A5050733356 @default.
• W3134700979 hasAuthorship W3134700979A5050892306 @default.
• W3134700979 hasAuthorship W3134700979A5055160753 @default.
• W3134700979 hasAuthorship W3134700979A5055585688 @default.
• W3134700979 hasAuthorship W3134700979A5057538695 @default.

• next